S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

EYPT EyePoint Pharmaceuticals Inc

19.55

-0.39 (-1.96%)

04 May 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more EyePoint Pharmaceuticals Charts.

Psivida Corp. News

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Tuesday 16 April 2024 (3 weeks ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

More Psivida Corp. News Articles

Newcrest Mining

S&P ASX 300 Metals and M...

Commonwealth Bank Of Aus...

Woodside Petroleum

Invesco QQQ Trust Series 1

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions